Author

Marcello Trevisani

Chiesi (Italy)ORCID 0009-0005-4384-6545Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Vanessa Pitozzi· 2 shared Barbara MontaniniiD· 1 shared Brintha SelvarajahiD· 1 shared Caterina FratiiD· 1 shared Costanza Anna Maria LagrastaiD· 1 shared Delphine GuillotiniD· 1 shared Denise MadedduiD· 1 shared Emanuela BocchiiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Vanessa Pitozzi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyBritish Journal of PharmacologyPeer-reviewedMar 22, 2026

Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model

Martina Bonatti, Vanessa Pitozzi, Paola Lorenza Caruso…·Barbara Montanini

This study uses RNA sequencing in a rat bleomycin model to show nintedanib reduces fibrosis and alters gene expression related to lipid metabolism and macrophages.

DOI 10.1111/bph.70311

ratbulk RNA-seq

𝕏 PostBluesky

Cell BiologyJCI InsightPeer-reviewedAug 13, 2024

Pyruvate metabolism dictates fibroblast sensitivity to GLS1 inhibition during fibrogenesis

Greg Contento, Jo-Anne A M Wilson, Brintha Selvarajah…·Rachel Clare Chambers

This study shows that pyruvate metabolism affects fibroblast response to GLS1 inhibition during fibrosis, suggesting combined targeting of pyruvate metabolism and glutaminolysis as a therapeutic strategy.

23 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky